We liked the charts of Gilead Sciences (GILD) on October 31 when we recommended, "Aggressive traders could go long GILD at current levels risking to $60. Our price targets are $75 and $91." Prices have just about reached our first target of $75 so another inspection of the charts is in order.
More from Investing
These recently downgraded names are displaying both quantitative and technical deterioration.
LCID's market cap has been deflated, so is it now a bargain, or can it slip further?
The most powerful thing an investor can do is embrace the idea that they don't know what the future holds.
There high-growth dividend stocks will be here over the long haul.